<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00070577</url>
  </required_header>
  <id_info>
    <org_study_id>030283</org_study_id>
    <secondary_id>03-AA-0283</secondary_id>
    <nct_id>NCT00070577</nct_id>
  </id_info>
  <brief_title>Influence of Age and Sex on Alcohol Metabolism and Acute Responses</brief_title>
  <official_title>Influence of Age and Sex on Alcohol Metabolism and Acute Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This study will examine age and sex differences in alcohol metabolism and the effects of&#xD;
      alcohol. Men and women differ in their ability to metabolize alcohol, possibly due to&#xD;
      differences between men and women in lean body mass, liver size, or the activity of enzymes&#xD;
      that act on alcohol in the liver. Also, older men and women are thought to be more sensitive&#xD;
      to alcohol, although the reasons for this are not clear.&#xD;
&#xD;
      Healthy men and women between 21 and 25 years of age and between 55 and 65 years of age who&#xD;
      are social drinkers may be eligible for this study. Candidates will be screened with&#xD;
      questionnaires about their general and mental health, alcohol use, and family history of&#xD;
      alcohol use and problems. They will have a physical examination, electrocardiogram (EKG),&#xD;
      routine blood tests, urinalysis to test for drugs of abuse, and a blood test to study the&#xD;
      gene responsible for enzymes that metabolize alcohol. Younger women will have a urine&#xD;
      pregnancy test and older women will have a test to confirm post-menopausal status.&#xD;
&#xD;
      Participants will have two study sessions at the NIH Clinical Center outpatient clinic. They&#xD;
      come to the clinic by taxi and, upon arrival, take a breathalyzer test for any measurable&#xD;
      alcohol levels. They are then given breakfast, after which two catheters (plastic tubes) are&#xD;
      placed, one in a vein in each arm. One tube is used to collect blood samples for measuring&#xD;
      hormone levels; the other is for infusing alcohol. The infusion is adjusted so that the&#xD;
      breath alcohol level is held constant for about 3 hours at a moderate level. Baseline&#xD;
      measurements are taken before the infusion begins. During and after the infusion, the&#xD;
      participants fill out questionnaires about their moods and feelings. Breath alcohol level and&#xD;
      heart rate measurements are monitored frequently. After the test, participants remain in the&#xD;
      clinic until their breath alcohol level drops below 0.02 g/L (generally 2 to 3 hours after&#xD;
      the infusion stops). They are given lunch and then sent home in a taxi.&#xD;
&#xD;
      Participants also undergo a dual energy x-ray absorptiometry (DEXA) scan to determine lean&#xD;
      body mass and a magnetic resonance imaging (MRI) scan of the abdomen to determine liver size.&#xD;
      For the DEXA scan, the subject lies still on a table for about 30 minutes while the whole&#xD;
      body is scanned using a small amount of radiation. For the MRI, the subject lies in a narrow&#xD;
      metal cylinder (the scanner) about 30 minutes for the scan.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies, including our studies using the alcohol clamp, have shown that alcohol&#xD;
      pharmacokinetics differ between women and men. Some of the factors that may contribute to&#xD;
      these sex differences in absorption, distribution and metabolism include variation in lean&#xD;
      body mass (and total body water), liver size and differences in activity or capacity of&#xD;
      alcohol metabolizing enzymes in the stomach and livers of women and men. A fundamental&#xD;
      difference between men and women is in the levels of the sex hormones estrogen and&#xD;
      testosterone, which can influence several of the above factors. Sex differences in alcohol&#xD;
      pharmacokinetics, and estrogen itself, have been postulated as determinants of the increased&#xD;
      susceptibility of women to alcohol-related liver disease. An additional area of interest is&#xD;
      sex- and age-related differences in sensitivity to the effects of alcohol. The elderly are&#xD;
      thought to be more sensitive to alcohol and show greater impairment than younger individuals.&#xD;
      However, it is not clear if these changes are due to pharmacokinetic or pharmacodynamic&#xD;
      factors.&#xD;
&#xD;
      The objectives of this project are (I) to evaluate the influence of age and sex on alcohol&#xD;
      elimination rates in men and women, and (II) to determine the influence of age and sex on the&#xD;
      initial response and acute adaptation to alcohol on measures of subjective perceptions of&#xD;
      alcohol effects and heart rate. This study will be conducted in 24 young and 24 older&#xD;
      participants, with equal numbers of males and females in each group. Comparison of alcohol&#xD;
      elimination rates across these groups and correlation with liver volume and sex steroid&#xD;
      levels will provide a means to examine the influence of sex hormones, estrogen and&#xD;
      testosterone, in age-related and sex-related differences in alcohol metabolism and liver&#xD;
      volume. This study will examine age- and sex- related differences in response to alcohol on&#xD;
      subjective measures of intoxication and mood, as well as on heart-rate and&#xD;
      psychophysiological responses to emotional visual stimuli (pictures). This study will also&#xD;
      evaluate the effect of acute alcohol administration on gene expression in peripheral blood&#xD;
      cells. Findings from these studies will provide important new data regarding the role of sex&#xD;
      steroids (estrogen and testosterone) on the metabolism of alcohol, and a better understanding&#xD;
      of age- and sex-related differences in metabolic processes that may underlie medically&#xD;
      important differences in the responses of individuals to alcohol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 29, 2003</start_date>
  <completion_date>May 3, 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment type="Actual">65</enrollment>
  <condition>Metabolism</condition>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:&#xD;
&#xD;
        This study will be conducted in social drinkers with no current or past history of alcohol&#xD;
        dependence or alcohol abuse. Inclusion criteria include:&#xD;
&#xD;
          1. Male and female participants between 21-25 years or 55-65 years of age.&#xD;
&#xD;
          2. Good health as determined by medical history, physical exam, EKG and lab tests.&#xD;
&#xD;
          3. Current non-smokers. Participants who quit smoking for over 1 year can be included.&#xD;
&#xD;
          4. Family-history negative, i.e., no family history of alcoholism in the first-or&#xD;
             second-degree.&#xD;
&#xD;
          5. Young women will have normal menstrual cycles and will be tested during the follicular&#xD;
             phase of their cycle (within 7 days of offset of menses) and must have a negative&#xD;
             urine pregnancy (hCG) test at the start of each study session.&#xD;
&#xD;
          6. Older women will be post-menopausal, with cessation of menses for at least 12 months&#xD;
             prior to enrollment into the study, and a serum follicle stimulating hormone (FSH)&#xD;
             level greater than 40 IU/L.&#xD;
&#xD;
          7. All participants must report the absence of flushing either currently or in the past,&#xD;
             based on the Alcohol Flushing Questionnaire, assessed during screening.&#xD;
&#xD;
          8. Participants must have no ferromagnetic objects in their bodies which might be&#xD;
             adversely affected by MRI (e.g. surgical clips; metal fragments in any part of the&#xD;
             body; cardiac or neurological pacemaker; cochlear or eye implant) - any doubt about&#xD;
             presence of these objects will result in exclusion from this study.&#xD;
&#xD;
        EXCLUSION CRITERIA:&#xD;
&#xD;
          1. Current or prior history of any disease, including cardiovascular, respiratory,&#xD;
             gastrointestinal, hepatic, renal, endocrine, or reproductive disorders, or a positive&#xD;
             hepatitis or HIV test at screening.&#xD;
&#xD;
          2. Current history of Axis-I psychiatric illness.&#xD;
&#xD;
          3. Current or prior history of any alcohol or drug dependence or abuse, as well as&#xD;
             non-drinkers (alcohol-naive individuals or current abstainers).&#xD;
&#xD;
          4. Alcohol use exceeding 14 drinks/week for males and 7 drinks/week for females, and use&#xD;
             of more than 4 drinks on any one occasion in the 6 months prior to the study.&#xD;
&#xD;
          5. Positive result on urine drug screen.&#xD;
&#xD;
          6. Pregnancy or intention to become pregnant for women. Female participants will undergo&#xD;
             a urine beta-hCG test to ensure they are not pregnant.&#xD;
&#xD;
          7. Use of oral contraceptive pills in younger female participants and use of hormone&#xD;
             replacement therapy in older female participants.&#xD;
&#xD;
          8. Menstrual cycle irregularities in younger female participants.&#xD;
&#xD;
          9. Use of prescription or OTC medications known to interact with alcohol within 2 weeks&#xD;
             of the study. These include, but may not be limited to: isosorbide, nitroglycerine,&#xD;
             benzodiazepines, warfarin, cough-and-cold preparations which contain anti-histamines,&#xD;
             codeine and/or acetaminophen, anti-depressants such as amitriptyline, clomipramine and&#xD;
             nefazodone, anti-diabetes medications such as glyburide, metformin and tolbutamide,&#xD;
             H2-antagonists for heartburn such as cimetidine and ranitidine, muscle relaxants, pain&#xD;
             medicines and anti-inflammatories such as aspirin, ibuprofen, acetaminophen, celecoxib&#xD;
             and naproxen, anti-epileptics including phenytoin and phenobarbital and narcotics&#xD;
             including darvocet, percocet and hydrocodone. Drugs known to inhibit or induce enzymes&#xD;
             that metabolize alcohol should not be used for 4 weeks prior to the study. These&#xD;
             include acetaminophen, chlorzoxazone, isoniazid, metronidazole and disulfiram.&#xD;
&#xD;
         10. Exclusions also include herbal preparations containing soy isoflavones (which may have&#xD;
             estrogenic properties).&#xD;
&#xD;
         11. Inability to undergo the MRI scan for liver volume due to claustrophobia or anxiety&#xD;
             when confined to small spaces such as the magnet bore, or due to the presence of&#xD;
             metallic implants.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aasmoe L, Aarbakke J. Sex-dependent induction of alcohol dehydrogenase activity in rats. Biochem Pharmacol. 1999 May 1;57(9):1067-72.</citation>
    <PMID>10796077</PMID>
  </reference>
  <reference>
    <citation>Ammon E, Sch√§fer C, Hofmann U, Klotz U. Disposition and first-pass metabolism of ethanol in humans: is it gastric or hepatic and does it depend on gender? Clin Pharmacol Ther. 1996 May;59(5):503-13.</citation>
    <PMID>8646821</PMID>
  </reference>
  <reference>
    <citation>Ayabe T, Tsutsumi O, Sakai H, Yoshikawa H, Yano T, Kurimoto F, Taketani Y. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer. Endocr J. 1997 Jun;44(3):419-24.</citation>
    <PMID>9279518</PMID>
  </reference>
  <verification_date>May 3, 2011</verification_date>
  <study_first_submitted>October 3, 2003</study_first_submitted>
  <study_first_submitted_qc>October 3, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2003</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <keyword>Alcohol Clamp</keyword>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Pharmacodynamics</keyword>
  <keyword>Alcohol</keyword>
  <keyword>Metabolism</keyword>
  <keyword>Response</keyword>
  <keyword>Age</keyword>
  <keyword>Sex</keyword>
  <keyword>Healthy Volunteer</keyword>
  <keyword>HV</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

